OVID THERAPEUTICS INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On November 10, 2021, Ovid Therapeutics Inc. (the "Company") issued a press release providing a business update and corporate highlights and announcing third quarter 2021 financial results. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference into this Item 2.02.

Item 7.01. Regulation FD Disclosure.

On November 10, 2021, the Company posted its Corporate Overview dated November 2021 to the "News & Events" subsection of the "Investors" tab on the Company's website at www.ovidrx.com.

The information provided in Items 2.02 and 7.01, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibit



Exhibit
  No.       Description

99.1          Press Release, dated November 10, 2021

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses